These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7674134)

  • 21. Topical chemoprophylaxis with silver sulphadiazine and silver nitrate chlorhexidine creams: emergence of sulphonamide-resistant Gram-negative bacilli.
    Lowbury EJ; Babb JR; Bridges K; Jackson DM
    Br Med J; 1976 Feb; 1(6008):493-6. PubMed ID: 814955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resistant Enterobacter cloacae in a burn center: the ineffectiveness of silver sulfadiazine.
    Gayle WE; Mayhall CG; Lamb VA; Apollo E; Haynes BW
    J Trauma; 1978 May; 18(5):317-23. PubMed ID: 660684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo and in vitro antimicrobial activity of silver sulfadiazine and cerium nitrate.
    Saffer LD; Rodeheaver GT; Hiebert JM; Edlich RF
    Surg Gynecol Obstet; 1980 Aug; 151(2):232-6. PubMed ID: 6773164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metal sulfonamides as antibacterial agents in topical therapy.
    Fox CL; Modak S; Stanford JW; Fox PL
    Scand J Plast Reconstr Surg; 1979; 13(1):89-94. PubMed ID: 451486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Serum and tissue silver levels after burns treated with silver compounds].
    Kartal A; Tatkan Y; Belviranli M; Sahin M; Duman S; Karahan O; Gurbilek M; Temur S
    J Chir (Paris); 1989 Dec; 126(12):676-81. PubMed ID: 2621235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical comparison of maphenide and silver sulphadiazine.
    Pegg SP; Ramsay K; Meldrum L; Laundy M
    Scand J Plast Reconstr Surg; 1979; 13(1):95-101. PubMed ID: 451487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of efficacy of 1% silver sulfadiazine and Acticoat for treatment of partial-thickness burn wounds.
    Muangman P; Chuntrasakul C; Silthram S; Suvanchote S; Benjathanung R; Kittidacha S; Rueksomtawin S
    J Med Assoc Thai; 2006 Jul; 89(7):953-8. PubMed ID: 16881426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Our experience with the use of cerium sulphadiazine in the treatment of extensive burns.
    Koller J; Orsag M
    Acta Chir Plast; 1998; 40(3):73-5. PubMed ID: 9782621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Burns and the use of silver sulphadiazine.
    McDougall IA
    Aust N Z J Surg; 1972 Nov; 42(2):174-8. PubMed ID: 4218758
    [No Abstract]   [Full Text] [Related]  

  • 30. Burn wound sepsis: effect of delayed treatment with topical chemotherapy on survival.
    Salisbury RE; Bevin AG; Steinkraus GE; Enterline DS
    J Trauma; 1980 Feb; 20(2):120-2. PubMed ID: 7354493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Topical silver sulphadiazine: side effects and urinary excretion.
    Lockhart SP; Rushworth A; Azmy AA; Raine PA
    Burns Incl Therm Inj; 1983 Sep; 10(1):9-12. PubMed ID: 6640389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Montmorillonite-chitosan-silver sulfadiazine nanocomposites for topical treatment of chronic skin lesions: in vitro biocompatibility, antibacterial efficacy and gap closure cell motility properties.
    Sandri G; Bonferoni MC; Ferrari F; Rossi S; Aguzzi C; Mori M; Grisoli P; Cerezo P; Tenci M; Viseras C; Caramella C
    Carbohydr Polym; 2014 Feb; 102():970-7. PubMed ID: 24507371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The treatment of sepsis in superficial burns: effect of 1% Silver Sulphadiazine.
    Sharma BC; Wosornu L; Paonaskar V
    Med J Zambia; 1979; 13(2):35-40. PubMed ID: 263370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of in vitro sensitivity to sulfadiazine silver.
    McManus AT; Denton CL; Mason AD
    Arch Surg; 1983 Feb; 118(2):161-6. PubMed ID: 6401421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of a new topical agent for burn therapy. Silver sulfadiazine (silvadene).
    Ballin JC
    JAMA; 1974 Nov; 230(8):1184-5. PubMed ID: 4479596
    [No Abstract]   [Full Text] [Related]  

  • 36. [Comparison of therapeutic value of various topical agents in Pseudomonas aeruginosa infection. An experimental study].
    Guo ZR
    Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1993 May; 9(3):181-3, 238. PubMed ID: 8402350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Best evidence topic report. Silver sulphadiazine cream in burns.
    Hussain S; Ferguson C
    Emerg Med J; 2006 Dec; 23(12):929-32. PubMed ID: 17130603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The preparation and invivo use of silver sulphadiazine cream for treatment of burns infected with Pseudomonas aeruginosa.
    Drake DJ; Froese EH
    Cent Afr J Med; 1975 Apr; 21(4):71-2. PubMed ID: 806345
    [No Abstract]   [Full Text] [Related]  

  • 39. Cerium nitrate-silver sulfadiazine cream in the treatment of burns: a prospective evaluation.
    Munster AM; Helvig E; Rowland S
    Surgery; 1980 Nov; 88(5):658-60. PubMed ID: 7434206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of silver sulfadiazine and gentamicin for topical prophylaxis against burn wound sepsis.
    Snelling CF; Ronald AR; Waters WR; Yaworski DS; Drulak K; Sunderland M
    Can Med Assoc J; 1978 Sep; 119(5):466-70. PubMed ID: 99223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.